Ken Griffin China Pharma Holdings, Inc. Transaction History

Citadel Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.21 - $0.39 $7,319 - $13,593	34,854 New	34,854 $7,000
Q3 2021 Nov 15, 2021	SELL	$0.53 - $0.91 $24,395 - $41,887	-46,030 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.57 - $0.99 $50,288 - $87,343	-88,226 Reduced 65.71%	46,030 $33,000
Q1 2021 May 17, 2021	BUY	$0.49 - $1.28 $59,888 - $156,442	122,221 Added 1015.55%	134,256 $113,000
Q4 2020 Feb 16, 2021	SELL	$0.36 - $0.55 $31,138 - $47,572	-86,495 Reduced 87.79%	12,035 $5,000
Q3 2020 Nov 16, 2020	BUY	$0.33 - $0.62 $32,514 - $61,088	98,530 New	98,530 $36,000
Q2 2020 Aug 14, 2020	SELL	$0.39 - $0.71 $8,492 - $15,460	-21,776 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.25 - $1.14 $1,002 - $4,571	-4,010 Reduced 15.55%	21,776 $11,000
Q4 2019 Feb 14, 2020	SELL	$0.22 - $0.27 $16,220 - $19,907	-73,730 Reduced 74.09%	25,786 $6,000
Q3 2019 Nov 14, 2019	BUY	$0.25 - $0.31 $9,639 - $11,953	38,559 Added 63.26%	99,516 $24,000
Q3 2018 Nov 13, 2018	BUY	$0.2 - $0.26 $19 - $25	98 Added 0.16%	60,957 $0
Q2 2018 Aug 10, 2018	SELL	$0.21 - $0.32 $18,726 - $28,536	-89,176 Reduced 59.44%	60,859 $0
Q1 2018 May 11, 2018	BUY	$0.17 - $0.58 $19,108 - $65,193	112,402 Added 298.68%	150,035 $48,000
Q4 2017 Feb 09, 2018	SELL	$0.16 - $0.2 $18,962 - $23,702	-118,513 Reduced 75.9%	37,633 $7,000
Q3 2017 Nov 09, 2017	BUY	$0.17 - $0.2 $26,544 - $31,229	156,146	156,146 $27,000

Ticker CPHI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 50,449,700
Market Cap $11.1M
Description
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. It...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.